Clinical review: primary influenza viral pneumonia
Jordi Rello1, Aurora Pop-Vicas
1Critical Care Department, Joan XXIII University Hospital, CIBERES Enfermedades Respiratorias, IISPV, Tarragona, Spain. jrello.hj23.ics@gencat.cat
Abstract:
Primary influenza pneumonia has a high mortality rate during pandemics, not only in immunocompromised individuals and patients with underlying comorbid conditions, but also in young healthy adults. Clinicians should maintain a high index of suspicion for this diagnosis in patients presenting with influenza-like symptoms that progress quickly (2 to 5 days) to respiratory distress and extensive pulmonary involvement. The sensitivity of rapid diagnostic techniques in identifying infections with the pandemic 2009 H1N1v influenza strain is currently suboptimal. The most reliable real-time reverse transcriptase-polymerase chain reaction molecular testing is available in limited clinical settings. Despite 6 months of pandemic circulation, most novel H1N1v pandemic strains remain susceptible to oseltamivir. Ensuring an appropriate oxygenation and ventilation strategy, as well as prompt initiation of antiviral therapy, is essential in management.
Insights
Primary influenza pneumonia, even in healthy adults, has a high mortality rate. Prompt diagnosis, oxygenation, ventilation, and antiviral therapy are crucial for managing severe cases of pandemic influenza.
Area of Science:
- Infectious Diseases
- Pulmonology
- Virology
Background:
- Primary influenza pneumonia presents a significant mortality risk during pandemics, affecting diverse populations including young, healthy adults.
- Rapid progression from influenza-like symptoms to severe respiratory distress and pulmonary involvement necessitates high clinical suspicion.
Purpose of the Study:
- To highlight the critical aspects of diagnosing and managing primary influenza pneumonia during pandemic situations.
- To emphasize the limitations of current rapid diagnostic tests for pandemic influenza strains.
Main Methods:
- Review of clinical presentations and outcomes associated with primary influenza pneumonia.
- Assessment of diagnostic test sensitivities and antiviral susceptibility patterns.
Main Results:
- Current rapid diagnostic tests show suboptimal sensitivity for pandemic 2009 H1N1v influenza.
- Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) offers reliable detection but has limited availability.
- Most pandemic H1N1v strains remain susceptible to oseltamivir.
Conclusions:
- Early clinical suspicion and prompt initiation of supportive care, including oxygenation and ventilation, are vital.
- Antiviral therapy with oseltamivir should be started promptly, given continued susceptibility.
- Improved diagnostic strategies and accessibility are needed for effective pandemic influenza management.
More Related Videos
Related Concept Videos
Influenza
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia II: Pathophysiology


